Moderna, Inc.

10-K & 10-Q Filings

Moderna is a biotechnology company that specializes in messenger RNA (mRNA) medicine. The company's platform uses mRNA to instruct cells to produce specific proteins or vaccine antigens, offering advantages over traditional medicine approaches. Moderna's strategy includes delivering an unrivaled respiratory vaccine franchise, advancing multiple latent virus and other vaccines, accelerating a large portfolio of late-stage clinical trials in individualized neoantigen therapy (INT) for cancer, and delivering the next-generation pipeline and platform. The company's platform consists of advances in mRNA science, delivery, and manufacturing process. Moderna's website is modernatx.com, and its stock ticker is MRNA.

12 mos ending Dec 31, 201812 mos ending Dec 31, 201912 mos ending Dec 31, 202012 mos ending Dec 31, 202112 mos ending Dec 31, 202212 mos ending Dec 31, 20233 mos ending Mar 31, 20233 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$135.07
60.21
803.39
18471.00
19263.00
6848.00
1862.00
167.00
119.28%-91.03%Cost of Revenue (-)
$
0.00
7.93
2617.00
5416.00
4693.00
792.00
96.00
-87.88%Gross Profit (+)
$
795.46
15854.00
13847.00
2155.00
1070.00
71.00
-93.36%Selling, General & Administrative (-)
$94.25
109.62
188.27
567.00
1132.00
1549.00
305.00
274.00
75.05%-10.16%Research & Development (-)
$454.08
496.31
1370.34
1991.00
3295.00
4845.00
1131.00
1063.00
60.56%-6.01%Operating Expenses (-)
$548.33
605.93
1558.61
2558.00
4427.00
6394.00
1436.00
1337.00
63.44%-6.89%Costs & Expenses (Total) (-)
$548.33
605.93
1566.54
5175.00
9843.00
11087.00
2228.00
1433.00
82.45%-35.68%Operating Income/Loss (+)
$-413.27
-545.72
-763.14
13296.00
9420.00
-4239.00
-366.00
-1266.00
-245.90%Non-operating Income/Expense (+)
$28.86
31.00
18.63
-11.00
155.00
297.00
61.00
101.00
59.40%65.57%Earnings before Tax (+)
$-384.41
-514.72
-744.51
13285.00
9575.00
-3942.00
-305.00
-1165.00
-281.97%Tax Expense (-)
$0.33
-0.69
2.55
1083.00
1213.00
772.00
-384.00
10.00
373.02%102.60%Income/Loss (Continuing Operations) (+)
$-384.73
-514.02
-747.06
12202.00
8362.00
-4714.00
79.00
-1175.00
-1587.34%Net Income/Loss (+)
$-384.73
-514.02
-747.06
12202.00
8362.00
-4714.00
79.00
-1175.00
-1587.34%Preferred & Other Distributions (-)
$17.12
Net Income/Loss (Common) (+)
$-401.86
-514.02
-747.06
12202.00
8362.00
-4714.00
79.00
-1175.00
-1587.34%EPS (Basic)
$-4.95
-1.55
-1.96
30.31
21.26
-12.33
0.20
-3.07
-1635.00%EPS (Diluted)
$-4.95
-1.55
-1.96
28.29
20.12
-12.33
0.19
-3.07
-1715.79%Weighted Avg Shares (Basic)
81.11
330.80
381.33
403.00
394.00
382.00
386.00
382.00
36.33%-1.04%Weighted Avg Shares (Diluted)
81.11
330.80
381.33
431.00
416.00
382.00
405.00
382.00
36.33%-5.68%Cash
$658.96
236.91
2624.88
6848.00
3205.00
2907.00
3441.00
2051.00
34.56%-40.40%Short-term Investments
$863.06
867.12
1983.76
3879.00
6697.00
5697.00
5482.00
6472.00
45.85%18.06%Receivables
$11.69
5.03
1390.56
3175.00
1385.00
892.00
1113.00
137.00
137.98%-87.69%Inventory
$
46.53
1441.00
949.00
202.00
732.00
295.00
-59.70%Prepaid Expenses (Current)
$28.40
19.40
252.15
728.00
1195.00
627.00
1354.00
645.00
85.69%-52.36%Other Assets (Current)
$0.90
0.34
Assets (Current)
$1563.01
1128.80
6297.88
16071.00
13431.00
10325.00
12122.00
9600.00
45.88%-20.81%Securities & Long-term Investments
$184.52
170.78
649.90
6855.00
8318.00
4677.00
7442.00
3638.00
90.89%-51.12%Property, Plant & Equipment (Net)
$211.98
86.41
387.09
1383.00
2139.00
2658.00
2135.00
2760.00
65.83%29.27%Other Assets
$2.64
203.43
1.88
360.00
1970.00
766.00
2426.00
731.00
210.74%-69.87%Assets (Non-current)
$399.14
460.62
1038.87
8598.00
12427.00
8101.00
12003.00
7129.00
82.59%-40.61%Assets (Total)
$1962.15
1589.42
7336.75
24669.00
25858.00
18426.00
24125.00
16729.00
56.51%-30.66%Accounts Payable
$110.28
74.74
487.95
2650.00
2636.00
2381.00
2068.00
1631.00
84.86%-21.13%Other Liabilities (Current)
$112.52
68.37
3900.86
6478.00
2287.00
634.00
1431.00
749.00
41.31%-47.66%Liabilities (Current)
$222.80
143.12
4388.81
9128.00
4923.00
3015.00
3499.00
2380.00
68.37%-31.98%Debt (Non-current)
$
132.36
109.87
599.00
912.00
575.00
831.00
575.00
-30.81%Other Liabilities
$209.10
139.13
276.69
797.00
900.00
982.00
932.00
957.00
36.25%2.68%Liabilities (Non-current)
$209.10
271.50
386.57
1396.00
1812.00
1557.00
1763.00
1532.00
49.41%-13.10%Liabilities (Total)
$431.91
414.61
4775.38
10524.00
6735.00
4572.00
5262.00
3912.00
60.30%-25.66%Retained Earnings
$-1006.63
-1500.00
-2243.52
9958.00
18320.00
13606.00
18399.00
12431.00
-32.44%AOCI
$-1.32
1.80
3.00
-24.00
-370.00
-123.00
-267.00
-101.00
62.17%Shareholder's Equity
$1530.24
1174.81
2561.38
14145.00
19123.00
13854.00
18863.00
12817.00
55.37%-32.05%Liabilities & Equity
$1962.15
1589.42
7336.75
24669.00
25858.00
18426.00
24125.00
16729.00
56.51%-30.66%Net Income/Loss
$-384.73
-514.02
-747.06
12202.00
8362.00
-4714.00
79.00
-1175.00
-1587.34%Depreciation & Amortization
$24.90
31.00
31.25
232.00
348.00
621.00
78.00
36.00
90.27%-53.85%Increase/Decrease in Working Capital
$42.58
53.66
-2577.05
-1308.00
3455.00
139.00
1144.00
-60.00
26.69%-105.24%Share-based Compensation
$72.56
81.12
93.02
142.00
226.00
305.00
75.00
101.00
33.26%34.67%Adjustments to Reconcile Net Income
$53.91
55.03
2774.03
1418.00
-3381.00
1596.00
-1304.00
186.00
96.91%114.26%Net Cash (Operating)
$-330.87
-458.97
2026.97
13620.00
4981.00
-3118.00
-1225.00
-989.00
19.27%Capital Expenditure
$105.77
31.55
67.45
284.00
400.00
792.00
198.00
196.00
49.58%-1.01%Net Cash (Investing)
$-372.47
-14.95
-1671.93
-8523.00
-5176.00
4206.00
2011.00
118.00
-94.13%Increase/Decrease in Equity
$564.45
47.26
2032.37
-733.00
-3264.00
-1107.00
-517.00
15.00
102.90%Interest Expenses
$3.00
8.53
14.00
25.00
39.00
67.05%Dividends Paid
$
Net Cash (Financing)
$1226.84
51.12
2033.19
-873.00
-3448.00
-1377.00
-542.00
14.00
102.58%Cash Taxes Paid
$0.29
0.42
0.57
480.00
2729.00
-357.00
Increase/Decrease in Cash
$523.50
-422.79
2388.24
4224.00
-3643.00
-289.00
244.00
-857.00
-451.23%Cash (Beginning)
$134.86
670.49
247.70
2636.00
6860.00
3217.00
3217.00
2928.00
88.59%-8.98%Cash (Ending)
$658.36
247.70
2635.93
6860.00
3217.00
2928.00
3461.00
2071.00
34.78%-40.16%NOPAT
$-412.95
-546.46
-762.56
12815.60
6735.18
-3408.84
-826.80
-1255.13
-51.81%Gross Margin %
99.01%
85.83%
71.88%
31.47%
57.47%
42.51%
Operating Margin %
-305.97%
-906.38%
-94.99%
71.98%
48.90%
-61.90%
-19.66%
-758.08%
NOPAT Margin %
-305.73%
-907.60%
-94.92%
69.38%
34.96%
-49.78%
-44.40%
-751.58%
Net Margin %
-284.84%
-853.73%
-92.99%
66.06%
43.41%
-68.84%
4.24%
-703.59%
Tax Rate %
0.08%
-0.14%
0.08%
3.61%
28.50%
19.58%
-125.90%
0.86%
ROA
-21.05%
-34.38%
-10.39%
51.95%
26.05%
-18.50%
-3.43%
-7.50%
ROE
-26.99%
-46.51%
-29.77%
90.60%
35.22%
-24.61%
-4.38%
-9.79%
ROIC
-417.01%
-6881.11%
477.29%
176.55%
-144.09%
-30.21%
-67.91%
Asset Turnover
0.07
0.04
0.11
0.75
0.74
0.37
0.08
0.01
Inventory Turnover
0.17
1.82
5.71
23.23
1.08
0.33
Equity Multiplier
1.28
1.35
2.86
1.74
1.35
1.33
1.28
1.31
Current Ratio
7.02
7.89
1.43
1.76
2.73
3.42
3.46
4.03
Quick Ratio
6.88
7.75
1.37
1.52
2.29
3.15
2.87
3.64
Debt/Equity Ratio
0.11
0.04
0.04
0.05
0.04
0.04
0.04
Interest Coverage Ratio
-137.85
-89.49
949.71
376.80
-108.69
Working Capital/Sales
-0.84
-1.30
-0.83
0.07
0.09
-0.04
0.32
-5.46
R&D/Sales
3.36
8.24
1.71
0.11
0.17
0.71
0.61
6.37
Dividend Payout Ratio %
Total Payout
$-561.45
-47.26
-2023.84
747.00
3289.00
1146.00
517.00
-15.00
-102.90%Payout Ratio %
-135.96%
-8.65%
-265.40%
5.83%
48.83%
33.62%
62.53%
-1.20%